Brian Feth and Jonathan Grinstein go behind the headlines to discuss the impact of a Republican administration on Federal ...

Pharmaceutical Technology® caught up with Brittany Hayes, PhD, Highly Potent & Oncology Platform Director at CordenPharma, ...

High-throughput screening (HTS) enables the rapid testing of numerous compounds against biological targets. By automating and ...

Scientific inquiry is unpredictable, and the data collected today might need to answer unforeseen questions tomorrow. Rigid ...

Shifting to automated, closed modular manufacturing systems is growing increasingly crucial for biopharmaceutical production.

Evolving industry demands are driving the need for greater flexibility and innovation in processing equipment for ...

Ascend’s fill/finish capacity in the US will also be expanded. “We founded Ascend with a vision to quilt together the best operators and technologies within the advanced manufacturing field. The ...

The complexities of tech transfer may be overcome by data-driven approaches, digital tools, and effective communication.

Balversa (erdafitinib) marks the first and only bladder cancer therapy to target FGFR3 alterations, with a demonstrated increase in overall survival from 7.8 months to 12.1 months.

A £520 million investment for manufacturing capacity was announced by Chancellor of the Exchequer, Rachel Reeves, but academic and industry leaders stress the money should be used to train personnel.

The new Institute for Cell Therapy Discovery and Innovation will utilize expertise to develop cell therapies for cancer, autoimmune diseases, and infections.

A genetic medicines customer has selected the company’s binders for commercial development of the customer’s product. Aptamer Group announced on Nov. 7, 2024 that one of its customers has advanced use ...